Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that finasteride 1 mg daily, taken before and after hair transplant surgery, significantly improved scalp hair coverage and density in men with androgenetic alopecia compared to placebo.

This source outlines what it takes to be a competent provider for transgender individuals, focusing on their health needs, disparities, and coverage, and examines medical biases and hormone treatment guidelines, alongside treatment options for different age groups, concluding with evolving trends in medical education.

In this study of patients with androgenetic alopecia, botulinum toxin type A was found to significantly increase hair counts and improve hair density and coverage, with enhanced results observed when combined with oral finasteride, revealing a safe and effective treatment approach without adverse effects.

This article reviews scalp flap surgery for hair restoration, emphasizing its ability to provide immediate and natural hair coverage compared to traditional hair transplantation, and reports no new clinical results.

This discussion reviews hair transplantation as a treatment for thinning, hairline restoration, or scar coverage in females, offering no new clinical findings.

This study reported that women with alopecia often face high out-of-pocket costs for over-the-counter treatments and camouflaging agents due to insufficient insurance coverage, which can significantly impact their financial well-being and ability to afford basic necessities.

This study found that ethnic and racial differences in dermatology service use in the U.S. may stem from patient preferences or insurance coverage policies rather than clinical needs.

This article discusses the challenges ESRD patients face with Medicare Part D, including high out-of-pocket costs and coverage gaps, but reports no new research data.

This study observed that oral administration of BeauTop, a Chinese herbal medicine, significantly increased hair growth indicators, including VEGF expression, hair follicles, and hair coverage in C57BL/6 mice.

In this study, the researchers reported that using a biodegradable ECM scaffold for large-area wound regeneration accelerated wound coverage and improved hair follicle neogenesis by activating the adaptive immune system.

This review discusses various surgical and nonsurgical techniques for facial masculinization in transgender men and reports no new clinical outcomes; the authors highlight the importance of understanding patient satisfaction and insurance coverage options.

In this study, hair follicle stem cell-derived exosomes enriched with miR-181a-5p accelerated hair regrowth and the transition from telogen to anagen in mice, with up to 90% hair coverage observed, suggesting enhanced activation of the Wnt/β-catenin pathway compared to controls.

This study highlights that hair and scalp camouflage techniques can enhance confidence and self-esteem in patients with hair loss disorders by reducing the visibility of scalp contrast, leading to a visual effect of denser hair coverage.

This study introduced and validated the VESALT, a visual extension of the Severity of Alopecia Tool, finding it offers improved reliability and user-friendliness over SALT by incorporating pattern recognition and broader coverage, including non-scalp regions, in assessing alopecia areata severity.

In this case study, a 37-year-old man with chronic hair loss and vertex baldness experienced significant hair regrowth, increased density, and improved appearance after receiving combined homoeopathic and aesthetic treatments, resulting in nearly complete coverage of bald areas.

This study found that among transgender and gender diverse adults, facial hair is important for gender affirmation but often causes dissatisfaction and financial strain due to inadequate insurance coverage for hair care treatments.

This study found that using a stevioside-based microneedle patch significantly increased minoxidil's solubility and skin absorption, promoting hair growth in animal models and achieving 67.5% area coverage by day 35, highlighting the potential of this novel delivery system for androgenetic alopecia treatment.

In this study, a parsley-derived n-hexane fraction formulated into a coconut oil-based nanoemulsion demonstrated significant hair regrowth comparable to 3% minoxidil, with near-complete coverage by day 17, suggesting potential as a topical hair growth treatment.

This review assessed randomised clinical trials on the efficacy and safety of topical and systemic JAK inhibitors for alopecia areata, finding significant hair coverage improvement with ritlecitinibe and baricitinibe, though prolonged treatment is often needed to maintain results.

This study observed that public interest in JAK-inhibitor treatments for alopecia areata significantly increased around the FDA approval in 2022 and heightened media coverage, suggesting an important role for patient education about these treatments.

This summary highlights key contents of the latest issue of the Austrian dermatology journal, SKIN, including coverage of the ÖADF conference program, introduction of a "Phlebology Certificate," and new SKINdeep open-access articles.

This case report described an 8-year-old Chihuahua with significant hair loss, where supplementation with horse placenta extract, taurine, and vitamin B complex led to marked hair regrowth and maintained coverage during a 76-week follow-up period, suggesting a potential non-invasive treatment option for alopecia in dogs.

This case report describes an adolescent boy with congenital triangular alopecia who showed significant hair regrowth after eight months of treatment with 5% topical minoxidil, achieving full coverage of the affected area without adverse effects.

This chapter reviews treatment options for androgenetic alopecia, noting FDA-approved finasteride and minoxidil for stabilizing or improving scalp coverage, positive off-label results with platelet-rich plasma, and effectiveness of hair transplantation using healthy follicular units.

This retrospective case series reports on the use of STRAVIX PL, a shelf-stable human umbilical tissue allograft, in managing recurrent pilonidal cyst wounds, suggesting potential benefits in reducing recurrence and providing durable wound coverage compared to traditional methods.

In this study, Ritlecitinib was reported as a newly approved treatment for alopecia areata that can be used in patients aged 12 and older; after 24 weeks, it resulted in 80% or more scalp hair coverage in treated patients compared to a placebo.

In this study, researchers found that the concentrations of cetostearyl alcohol, shea butter, and coconut oil significantly affected the in vitro spreadability of heat protectants, suggesting that optimizing these components could improve product coverage and thermal protection on hair.

This source reports that clinical trials found oral baricitinib significantly improved hair regrowth in patients with severe alopecia areata, with 38.8% achieving at least 80% scalp hair coverage after 36 weeks on a 4-mg dose, compared to 6.2% with placebo in trial 1.

In this study, PRP treatment improved hair loss in 40 female patients with female pattern alopecia, with most progressing to better grades of hair coverage after 6 months, while only minor pain was occasionally reported as an adverse effect.

This article discusses the potential benefits of using modern combination grafting techniques in hair restoration surgery, highlighting the enhanced efficiency and cosmetic coverage compared to traditional follicular unit transplantation, but presents no new clinical results.